SBIR/STTR Research Award
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications
Award amount
$1,498,045Program and phase
SBIR · Phase IIAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INTRALYTIX INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HXUNCLKMHAP4
- Solicitation number
- PHS-2021-1
- Topic code
- 95
Research abstract
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Phage biocontrol of Vibrio parahaemolyticus for enhancing seafood safety
- A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications
- Commercialization of Bacteriophages against the Larval Shellfish Pathogens, Vibrio tubaishii and Vibrio coralliilyticus
- Bacteriophages for reducing Vibrio tubiashii associated mortality of shellfish
- Phage preparation for managing Salmonella in foods
Research funding history
14 SBIR/STTR records share this UEI (2000–2022). Reported award amounts total $5,814,893. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Agriculture, Department of Health and Human Services